• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的各年龄组癫痫全球负担分析(1990 - 2021年):利用《2021年全球疾病负担》数据

A population-based analysis of the global burden of epilepsy across all age groups (1990-2021): utilizing the Global Burden of Disease 2021 data.

作者信息

Yang Ling-Zhi, Guo Yi, Wang Zhi-Qiang, Zhang Chen-Qi

机构信息

The Department of Neurology, Chengdu BOE Hospital, Chengdu, Sichuan, China.

The Department of Neurology, Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.

出版信息

Front Neurol. 2024 Dec 12;15:1448596. doi: 10.3389/fneur.2024.1448596. eCollection 2024.

DOI:10.3389/fneur.2024.1448596
PMID:39726763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11669576/
Abstract

OBJECTIVE

To investigate the trends in epilepsy prevalence, incidence, mortality, and disability-adjusted life-years (DALYs) in all ages, with risk factors for epilepsy - associated death, from 1990 to 2021.

METHODS

Using the standardized Global Burden of Disease (GBD) methodologies, we evaluated the burden of epilepsy in 204 countries and regions from 1990 to 2021, aiming to derive a more precise representation of the health burden posed by epilepsy by considering four distinct types of epidemiological data, namely the prevalence, incidence, mortality, and DALYs. The presented data were meticulously estimated and displayed both as numerical counts and as age-standardized rates per 100,000 persons of the population. All estimates were calculated with 95% uncertainty intervals (UI).

FINDING

In 2021, there were 24,220,856 (95% UI: 18,476,943-30,677,995) patients with epilepsy, with an age-standardized prevalence rate (ASPR) of 307.38 per 100,000 persons (95% UI: 234.71-389.02) and an age-standardized incidence rate (ASIR) of 42.821 per 100,000 persons (95% UI: 31.24-53.72).The global age-standardized mortality rate (ASMR) of epilepsy was 1.74 per 100,000 population (95% UI: 1.46-1.92); The age-standardized DALYs rate (ASDR) were 177.85 per 100,000 population (95% UI: 137.66-225.90); 154.25 per 100,000 population for females [114.73-201.76], and 201.29 per 100,000 population for males [157.93-252.74]. All of the ASPR, ASIR, ASMR and ASDR of males were higher than those of females, and the ASIR of epilepsy was the highest in children aged 0-14, at 61.00(95% UI: 39.09-86.21), while the older adult group aged 70+ has the highest ASMR of 5.67(95% UI: 4.76-6.18). From 1990 to 2021, the number of epilepsy-related deaths and DALYs both decreased. However, the ASPR of epilepsy increased by about 6.9% (95% UI: -0.10-0.26), and the ASIR increased by almost 12% (95% UI: 0.05-0.33). The trends in ASPR, ASIR, ASMR and ASDR exhibited notable variations across different regions.

CONCLUSION

Epilepsy is an increasing global health challenge with rising prevalence and incidence. Results of this cross-sectional study suggest that despite the global decline in deaths and DALYs, Epilepsy remains an important cause of disability and death, especially in low SDI regions. An improved understanding of the epidemiology of epilepsy may potentially have considerable benefits in reducing the global burden of epilepsy, by aiding in policy-making in low-income countries, provide data support for research on epilepsy medications and treatment methods.

摘要

目的

调查1990年至2021年各年龄段癫痫的患病率、发病率、死亡率和伤残调整生命年(DALYs)趋势,以及癫痫相关死亡的危险因素。

方法

使用标准化的全球疾病负担(GBD)方法,我们评估了1990年至2021年204个国家和地区的癫痫负担,旨在通过考虑四种不同类型的流行病学数据,即患病率、发病率、死亡率和DALYs,更精确地反映癫痫造成的健康负担。所呈现的数据经过精心估算,并以数值计数和每10万人的年龄标准化率两种形式展示。所有估算均计算了95%的不确定性区间(UI)。

结果

2021年,癫痫患者有24,220,856例(95% UI:18,476,943 - 30,677,995),年龄标准化患病率(ASPR)为每10万人307.38例(95% UI:234.71 - 389.02),年龄标准化发病率(ASIR)为每10万人42.821例(95% UI:31.24 - 53.72)。癫痫的全球年龄标准化死亡率(ASMR)为每10万人口1.74例(95% UI:1.46 - 1.92);年龄标准化DALYs率(ASDR)为每10万人口177.85例(95% UI:137.66 - 225.90);女性为每10万人口154.25例[114.73 - 201.76],男性为每10万人口201.29例[157.93 - 252.74]。男性的所有ASPR、ASIR、ASMR和ASDR均高于女性,癫痫的ASIR在0 - 14岁儿童中最高,为61.00(95% UI:39.09 - 86.21),而70岁及以上的老年人群ASMR最高,为5.67(95% UI:4.76 - 6.18)。1990年至2021年,癫痫相关死亡人数和DALYs均有所下降。然而,癫痫的ASPR增加了约6.9%(95% UI: - 0.10 - 0.26),ASIR增加了近12%(95% UI:0.05 - 0.33)。ASPR、ASIR、ASMR和ASDR的趋势在不同地区呈现出显著差异。

结论

癫痫是一个日益严峻的全球健康挑战,患病率和发病率不断上升。这项横断面研究的结果表明,尽管全球死亡人数和DALYs有所下降,但癫痫仍然是残疾和死亡的重要原因,尤其是在低社会人口指数地区。更好地了解癫痫流行病学可能有助于低收入国家制定政策,为癫痫药物和治疗方法的研究提供数据支持,从而在减轻全球癫痫负担方面可能带来相当大的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/2cfc619f2aee/fneur-15-1448596-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/c533b33db66d/fneur-15-1448596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/b536ae8fbbb2/fneur-15-1448596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/fd186584d5ca/fneur-15-1448596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/cc3a5241fb89/fneur-15-1448596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/c0f8c978303d/fneur-15-1448596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/2cfc619f2aee/fneur-15-1448596-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/c533b33db66d/fneur-15-1448596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/b536ae8fbbb2/fneur-15-1448596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/fd186584d5ca/fneur-15-1448596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/cc3a5241fb89/fneur-15-1448596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/c0f8c978303d/fneur-15-1448596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd4/11669576/2cfc619f2aee/fneur-15-1448596-g006.jpg

相似文献

1
A population-based analysis of the global burden of epilepsy across all age groups (1990-2021): utilizing the Global Burden of Disease 2021 data.基于人群的各年龄组癫痫全球负担分析(1990 - 2021年):利用《2021年全球疾病负担》数据
Front Neurol. 2024 Dec 12;15:1448596. doi: 10.3389/fneur.2024.1448596. eCollection 2024.
2
Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.1990 - 2021年全球、区域和国家的地中海贫血负担:全球疾病负担研究2021的系统分析
EClinicalMedicine. 2024 May 6;72:102619. doi: 10.1016/j.eclinm.2024.102619. eCollection 2024 Jun.
3
The global, regional, and national burden of paralytic ileus and intestinal obstruction, 1990 to 2021: a cross-sectional analysis from the 2021 global burden of disease study.1990年至2021年全球、区域和国家麻痹性肠梗阻和肠梗阻负担:来自2021年全球疾病负担研究的横断面分析
Int J Surg. 2025 Feb 1;111(2):1773-1787. doi: 10.1097/JS9.0000000000002189.
4
Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels.中国 1990 年至 2021 年以及 15 年预测的子宫癌负担:系统分析与全球水平的比较。
Reprod Health. 2024 Oct 10;21(1):144. doi: 10.1186/s12978-024-01882-2.
5
Temporal trends of thyroid cancer in China and globally from 1990 to 2021: an analysis of the global burden of Disease Study 2021.中国和全球甲状腺癌的时间趋势:2021 年全球疾病负担研究分析。
Sci Rep. 2024 Oct 26;14(1):25538. doi: 10.1038/s41598-024-77663-5.
6
Burden of esophageal cancer between 2010 and 2019 in Asian countries by geographical region and sociodemographic index: A comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的食管癌负担:与全球数据的比较。
Thorac Cancer. 2023 Aug;14(24):2361-2407. doi: 10.1111/1759-7714.15026. Epub 2023 Jul 17.
7
Global, regional, and national burden of asthma from 1990 to 2021: A systematic analysis of the global burden of disease study 2021.1990年至2021年全球、区域和国家的哮喘负担:全球疾病负担研究2021的系统分析
Chin Med J Pulm Crit Care Med. 2025 Mar 12;3(1):50-59. doi: 10.1016/j.pccm.2025.02.005. eCollection 2025 Mar.
8
Evolving trends and burden of idiopathic epilepsy among children (0-14 years), 1990-2021: a systematic analysis for the Global Burden of Disease study 2021.1990 - 2021年0至14岁儿童特发性癫痫的演变趋势与负担:2021年全球疾病负担研究的系统分析
Front Neurol. 2025 Mar 17;16:1548477. doi: 10.3389/fneur.2025.1548477. eCollection 2025.
9
Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021.1990 - 2021年全球、区域和国家缺血性卒中负担:基于2021年全球疾病负担研究数据的分析
EClinicalMedicine. 2024 Jul 27;75:102758. doi: 10.1016/j.eclinm.2024.102758. eCollection 2024 Sep.
10
Global trends of interstitial lung diseases from 1990 to 2019: an age-period-cohort study based on the Global Burden of Disease study 2019, and projections until 2030.1990年至2019年期间间质性肺疾病的全球趋势:基于2019年全球疾病负担研究的年龄-时期-队列研究及到2030年的预测
Front Med (Lausanne). 2023 Jul 24;10:1141372. doi: 10.3389/fmed.2023.1141372. eCollection 2023.

引用本文的文献

1
Comparative effectiveness of non-pharmacological interventions on anxiety, depression, and quality of life in patients with epilepsy: a systematic review and network meta-analysis.非药物干预对癫痫患者焦虑、抑郁及生活质量的比较效果:一项系统评价和网状Meta分析
Front Psychiatry. 2025 Jul 30;16:1624276. doi: 10.3389/fpsyt.2025.1624276. eCollection 2025.
2
Global, regional, and national children and adolescent epilepsy burden, 1990-2021: an analysis based on the global burden of disease study 2021.1990 - 2021年全球、区域和国家儿童及青少年癫痫负担:基于2021年全球疾病负担研究的分析
Ann Med. 2025 Dec;57(1):2534087. doi: 10.1080/07853890.2025.2534087. Epub 2025 Jul 17.

本文引用的文献

1
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes.对 20979 名癫痫患者进行外显子组测序,揭示了不同疾病亚型之间共享和独特的超罕见遗传风险。
Nat Neurosci. 2024 Oct;27(10):1864-1879. doi: 10.1038/s41593-024-01747-8. Epub 2024 Oct 3.
2
Beyond the Liver: Neurologic Manifestations of Alcohol Use.超越肝脏:酒精使用的神经表现。
Clin Liver Dis. 2024 Nov;28(4):681-697. doi: 10.1016/j.cld.2024.06.004. Epub 2024 Jul 23.
3
A multicultural comparative study of self-stigma in epilepsy: Differences across four cultures.
癫痫自我污名化的多元文化比较研究:四种文化间的差异
Epilepsia Open. 2024 Dec;9(6):2283-2293. doi: 10.1002/epi4.13051. Epub 2024 Sep 26.
4
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球、区域和国家的卒中负担及其风险因素,1990-2021 年:2021 年全球疾病负担研究的系统分析。
Lancet Neurol. 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7.
5
Sleep maintains excitatory synapse diversity in the cortex and hippocampus.睡眠维持皮质和海马体兴奋性突触的多样性。
Curr Biol. 2024 Aug 19;34(16):3836-3843.e5. doi: 10.1016/j.cub.2024.07.032. Epub 2024 Aug 2.
6
Subacute encephalopathy with seizures in alcoholics (SESA) syndrome: Relevant questions.酒精性亚急性脑病变伴癫痫(SESA)综合征:相关问题。
Epilepsy Behav. 2024 Oct;159:109968. doi: 10.1016/j.yebeh.2024.109968. Epub 2024 Aug 1.
7
Neurocysticercosis Prevalence and Characteristics in Communities of Sinda District in Zambia: A Cross-Sectional Study.赞比亚辛达区社区的神经囊虫病流行情况和特征:一项横断面研究。
J Epidemiol Glob Health. 2024 Sep;14(3):1180-1190. doi: 10.1007/s44197-024-00271-z. Epub 2024 Jul 9.
8
Risk of COVID-19 infection and seizure exacerbation among patients with epilepsy during the peak of Omicron wave.奥密克戎变异株流行期间癫痫患者 COVID-19 感染和癫痫发作加重的风险。
Epilepsia Open. 2024 Aug;9(4):1416-1425. doi: 10.1002/epi4.12978. Epub 2024 May 25.
9
Quality of life in people with epilepsy: Associations with resilience, internalized stigma, and clinical factors in a low-income population.癫痫患者的生活质量:在低收入人群中与韧性、内化污名和临床因素的关联。
Epilepsy Behav. 2024 Jun;155:109801. doi: 10.1016/j.yebeh.2024.109801. Epub 2024 Apr 25.
10
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.